ratiopharm direct GmbH

Within the ratiopharm Group, ratiopharm direct GmbH serves as the marketing organization for the following portfolio:
 

• Oncological generics
   
• Generics for clinical use
   
• NCEs, i.e. patented substances used primarily in the field of oncology
   
• Biologics

ratiopharm direct was founded in 2005.

Bringing our experience to the hospital

ratiopharm has set itself the target of entering the European hospital business through its subsidiary ratiopharm direct. Additionally, ratiopharm direct has been founded to show the commitment and focus we have in setting up the European oncology business. The ratiopharm direct portfolio comprises quality oncology generics and - in the future - will include innovative products and biologics.

ratiopharm direct is your new partner in hospitals with the goal of providing an innovative and unique approach through the combination of its portfolio: